Tri Locum Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-36,460
Closed -$2.38M 71
2022
Q3
$2.38M Buy
+36,460
New +$2.38M 0.65% 32